Maxim Group Downgrades Cyclo Therapeutics (CYTH) to Hold

March 20, 2023 12:31 PM EDT
Get Alerts CYTH Hot Sheet
Price: $1.28 -0.78%

Rating Summary:
    0 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 14 | Down: 3 | New: 43
Join SI Premium – FREE

Maxim Group analyst Jason McCarthy downgraded Cyclo Therapeutics (NASDAQ: CYTH) from Buy to Hold.

For an analyst ratings summary and ratings history on Cyclo Therapeutics click here. For more ratings news on Cyclo Therapeutics click here.

Shares of Cyclo Therapeutics closed at $1.11 yesterday.

You May Also Be Interested In

Related Categories